Literature DB >> 16195874

Clinical features of familial moyamoya disease.

Rina Nanba1, Satoshi Kuroda, Mitsuhiro Tada, Tatsuya Ishikawa, Kiyohiro Houkin, Yoshinobu Iwasaki.   

Abstract

OBJECTS: This study aims to clarify the genetic background of moyamoya disease by comparing clinical features between familial and sporadic cases to reveal the responsible genes for familial moyamoya disease.
METHODS: This study included 155 Japanese patients with moyamoya disease, which included 24 familial cases (10 family pedigrees) and 131 sporadic cases. Clinical features were compared between the familial and sporadic cases. RESULTS AND
CONCLUSION: A female preponderance was significantly more prominent in the familial than in the sporadic group (P=0.0421). Mean age at onset was significantly lower in familial than in sporadic cases (P=0.004). In eight parent-offspring pairs, mean age at onset was significantly lower in the second than in the first generation (P<0.0001). These results suggest that familial moyamoya disease is associated with genetic anticipation and female predominance and that a genetic analysis study focused on expanded triplet repeats may clarify the pathogenesis of the disease.

Entities:  

Mesh:

Year:  2005        PMID: 16195874     DOI: 10.1007/s00381-005-1230-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  25 in total

1.  Linkage analysis of moyamoya disease on chromosome 6.

Authors:  T K Inoue; K Ikezaki; T Sasazuki; T Matsushima; M Fukui
Journal:  J Child Neurol       Date:  2000-03       Impact factor: 1.987

2.  Worldwide distribution of moyamoya disease.

Authors:  Y Goto; Y Yonekawa
Journal:  Neurol Med Chir (Tokyo)       Date:  1992-11       Impact factor: 1.742

3.  Trinucleotide repeats not the only cause of anticipation.

Authors:  F C Fraser
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

4.  Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey.

Authors:  K Wakai; A Tamakoshi; K Ikezaki; M Fukui; T Kawamura; R Aoki; M Kojima; Y Lin; Y Ohno
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

5.  A survey of moyamoya disease in Hawaii.

Authors:  J F Graham; A Matoba
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

6.  Familial intracranial aneurysms.

Authors:  A M Lozano; R Leblanc
Journal:  J Neurosurg       Date:  1987-04       Impact factor: 5.115

7.  Familial occurrence of moyamoya disease in the mother and four daughters including identical twins.

Authors:  Y Kaneko; N Imamoto; H Mannoji; M Fukui
Journal:  Neurol Med Chir (Tokyo)       Date:  1998-06       Impact factor: 1.742

8.  Familial subarachnoid hemorrhage: distinctive features and patterns of inheritance.

Authors:  J E Bromberg; G J Rinkel; A Algra; C M van Duyn; P Greebe; L M Ramos; J van Gijn
Journal:  Ann Neurol       Date:  1995-12       Impact factor: 10.422

9.  Intracranial aneurysms and heredity.

Authors:  O Norrgård; K A Angquist; H Fodstad; A Forsell; M Lindberg
Journal:  Neurosurgery       Date:  1987-02       Impact factor: 4.654

10.  Clinical observations on familial cluster headache.

Authors:  P Torelli; G C Manzoni
Journal:  Neurol Sci       Date:  2003-06       Impact factor: 3.307

View more
  11 in total

1.  RNF213 variants in a child with PHACE syndrome and moyamoya vasculopathy.

Authors:  Kala F Schilter; Jack E Steiner; Wendy Demos; Mohit Maheshwari; Jeremy W Prokop; Elizabeth Worthey; Beth A Drolet; Dawn H Siegel
Journal:  Am J Med Genet A       Date:  2017-07-07       Impact factor: 2.802

2.  Surgical revascularisation for childhood moyamoya.

Authors:  J Ng; D Thompson; J P S Lumley; D E Saunders; V Ganesan
Journal:  Childs Nerv Syst       Date:  2012-05-09       Impact factor: 1.475

Review 3.  Single Nucleotide Polymorphism in Patients with Moyamoya Disease.

Authors:  Young Seok Park
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

4.  Long-term Outcome of Motor Function in a Child with Moyamoya Disease: A Case Report.

Authors:  Ki Seok Nam
Journal:  J Phys Ther Sci       Date:  2014-01-08

Review 5.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

6.  The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.

Authors:  Young Seok Park; Hui Jeong An; Jung Oh Kim; Won Seop Kim; In Bo Han; Ok Joon Kim; Nam Keun Kim; Dong-Seok Kim
Journal:  Int J Mol Sci       Date:  2017-11-21       Impact factor: 5.923

7.  Ethnic variation and the relevance of homozygous RNF 213 p.R4810.K variant in the phenotype of Indian Moya moya disease.

Authors:  Arun K; C M Shafeeque; Jayanand B Sudhir; Moinak Banerjee; Sylaja P N
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

8.  MMD-associated RNF213 SNPs encode dominant-negative alleles that globally impair ubiquitylation.

Authors:  Abhishek Bhardwaj; Robert S Banh; Wei Zhang; Sachdev S Sidhu; Benjamin G Neel
Journal:  Life Sci Alliance       Date:  2022-02-08

9.  Is there a role for treating inflammation in moyamoya disease?: a review of histopathology, genetics, and signaling cascades.

Authors:  Adam M H Young; Surya K Karri; Christopher S Ogilvy; Ninghui Zhao
Journal:  Front Neurol       Date:  2013-08-14       Impact factor: 4.003

10.  Moyamoya disease mimicking encephalitis.

Authors:  Maryam Khalesi; Masoud Pezeshki Rad; Abdolkarim Hamedi; Mohammad Hassan Aelami
Journal:  Iran J Med Sci       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.